vs

Side-by-side financial comparison of Howmet Aerospace (HWM) and Steris (STE). Click either name above to swap in a different company.

Howmet Aerospace is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.4× Steris). Howmet Aerospace runs the higher net margin — 17.2% vs 12.9%, a 4.3% gap on every dollar of revenue. On growth, Howmet Aerospace posted the faster year-over-year revenue change (14.6% vs 9.2%). Howmet Aerospace produced more free cash flow last quarter ($530.0M vs $199.5M). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs 9.0%).

Howmet Aerospace Inc. is an American aerospace company based in Pittsburgh, Pennsylvania. The company manufactures components for jet engines, fasteners, titanium structures for aerospace applications, and forged aluminum wheels for heavy trucks.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

HWM vs STE — Head-to-Head

Bigger by revenue
HWM
HWM
1.4× larger
HWM
$2.2B
$1.5B
STE
Growing faster (revenue YoY)
HWM
HWM
+5.5% gap
HWM
14.6%
9.2%
STE
Higher net margin
HWM
HWM
4.3% more per $
HWM
17.2%
12.9%
STE
More free cash flow
HWM
HWM
$330.5M more FCF
HWM
$530.0M
$199.5M
STE
Faster 2-yr revenue CAGR
STE
STE
Annualised
STE
15.8%
9.0%
HWM

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HWM
HWM
STE
STE
Revenue
$2.2B
$1.5B
Net Profit
$372.0M
$192.9M
Gross Margin
43.8%
Operating Margin
22.6%
18.3%
Net Margin
17.2%
12.9%
Revenue YoY
14.6%
9.2%
Net Profit YoY
18.5%
11.2%
EPS (diluted)
$0.92
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HWM
HWM
STE
STE
Q4 25
$2.2B
$1.5B
Q3 25
$2.1B
$1.5B
Q2 25
$2.1B
$1.4B
Q1 25
$1.9B
$1.5B
Q4 24
$1.9B
$1.4B
Q3 24
$1.8B
$1.3B
Q2 24
$1.9B
$1.3B
Q1 24
$1.8B
$1.1B
Net Profit
HWM
HWM
STE
STE
Q4 25
$372.0M
$192.9M
Q3 25
$385.0M
$191.9M
Q2 25
$407.0M
$177.4M
Q1 25
$344.0M
$145.7M
Q4 24
$314.0M
$173.5M
Q3 24
$332.0M
$150.0M
Q2 24
$266.0M
$145.4M
Q1 24
$243.0M
$-1.4M
Gross Margin
HWM
HWM
STE
STE
Q4 25
43.8%
Q3 25
44.2%
Q2 25
45.1%
Q1 25
43.3%
Q4 24
44.5%
Q3 24
43.6%
Q2 24
44.7%
Q1 24
40.2%
Operating Margin
HWM
HWM
STE
STE
Q4 25
22.6%
18.3%
Q3 25
25.9%
18.2%
Q2 25
25.4%
17.7%
Q1 25
25.4%
14.6%
Q4 24
23.5%
17.9%
Q3 24
22.9%
16.5%
Q2 24
21.2%
14.5%
Q1 24
20.2%
22.0%
Net Margin
HWM
HWM
STE
STE
Q4 25
17.2%
12.9%
Q3 25
18.4%
13.1%
Q2 25
19.8%
12.8%
Q1 25
17.7%
9.8%
Q4 24
16.6%
12.7%
Q3 24
18.1%
11.3%
Q2 24
14.1%
11.4%
Q1 24
13.3%
-0.1%
EPS (diluted)
HWM
HWM
STE
STE
Q4 25
$0.92
$1.96
Q3 25
$0.95
$1.94
Q2 25
$1.00
$1.79
Q1 25
$0.84
$1.48
Q4 24
$0.76
$1.75
Q3 24
$0.81
$1.51
Q2 24
$0.65
$1.46
Q1 24
$0.59
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HWM
HWM
STE
STE
Cash + ST InvestmentsLiquidity on hand
$742.0M
$423.7M
Total DebtLower is stronger
$3.0B
$1.9B
Stockholders' EquityBook value
$5.4B
$7.2B
Total Assets
$11.2B
$10.6B
Debt / EquityLower = less leverage
0.57×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HWM
HWM
STE
STE
Q4 25
$742.0M
$423.7M
Q3 25
$659.0M
$319.2M
Q2 25
$545.0M
$279.7M
Q1 25
$536.0M
$171.7M
Q4 24
$564.0M
$155.2M
Q3 24
$475.0M
$172.2M
Q2 24
$752.0M
$198.3M
Q1 24
$533.0M
$207.0M
Total Debt
HWM
HWM
STE
STE
Q4 25
$3.0B
$1.9B
Q3 25
$3.2B
$1.9B
Q2 25
$3.3B
$1.9B
Q1 25
$3.3B
$1.9B
Q4 24
$3.3B
$2.0B
Q3 24
$3.4B
$2.2B
Q2 24
$3.7B
$2.2B
Q1 24
$3.7B
$3.1B
Stockholders' Equity
HWM
HWM
STE
STE
Q4 25
$5.4B
$7.2B
Q3 25
$5.1B
$7.0B
Q2 25
$5.0B
$7.0B
Q1 25
$4.8B
$6.6B
Q4 24
$4.6B
$6.4B
Q3 24
$4.5B
$6.6B
Q2 24
$4.3B
$6.4B
Q1 24
$4.1B
$6.3B
Total Assets
HWM
HWM
STE
STE
Q4 25
$11.2B
$10.6B
Q3 25
$11.2B
$10.4B
Q2 25
$11.0B
$10.4B
Q1 25
$10.8B
$10.1B
Q4 24
$10.5B
$10.0B
Q3 24
$10.6B
$10.2B
Q2 24
$10.7B
$10.1B
Q1 24
$10.4B
$11.1B
Debt / Equity
HWM
HWM
STE
STE
Q4 25
0.57×
0.27×
Q3 25
0.62×
0.27×
Q2 25
0.65×
0.27×
Q1 25
0.69×
0.29×
Q4 24
0.73×
0.32×
Q3 24
0.75×
0.33×
Q2 24
0.86×
0.35×
Q1 24
0.90×
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HWM
HWM
STE
STE
Operating Cash FlowLast quarter
$654.0M
$298.2M
Free Cash FlowOCF − Capex
$530.0M
$199.5M
FCF MarginFCF / Revenue
24.4%
13.3%
Capex IntensityCapex / Revenue
5.7%
6.6%
Cash ConversionOCF / Net Profit
1.76×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HWM
HWM
STE
STE
Q4 25
$654.0M
$298.2M
Q3 25
$531.0M
$287.8M
Q2 25
$446.0M
$420.0M
Q1 25
$253.0M
$260.8M
Q4 24
$480.0M
$332.8M
Q3 24
$244.0M
$250.7M
Q2 24
$397.0M
$303.7M
Q1 24
$177.0M
$254.8M
Free Cash Flow
HWM
HWM
STE
STE
Q4 25
$530.0M
$199.5M
Q3 25
$423.0M
$201.3M
Q2 25
$344.0M
$326.4M
Q1 25
$134.0M
$189.9M
Q4 24
$378.0M
$243.6M
Q3 24
$162.0M
$148.8M
Q2 24
$342.0M
$195.7M
Q1 24
$95.0M
$163.3M
FCF Margin
HWM
HWM
STE
STE
Q4 25
24.4%
13.3%
Q3 25
20.2%
13.8%
Q2 25
16.8%
23.5%
Q1 25
6.9%
12.8%
Q4 24
20.0%
17.8%
Q3 24
8.8%
11.2%
Q2 24
18.2%
15.3%
Q1 24
5.2%
14.6%
Capex Intensity
HWM
HWM
STE
STE
Q4 25
5.7%
6.6%
Q3 25
5.2%
5.9%
Q2 25
5.0%
6.7%
Q1 25
6.1%
4.8%
Q4 24
5.4%
6.5%
Q3 24
4.5%
7.7%
Q2 24
2.9%
8.4%
Q1 24
4.5%
8.2%
Cash Conversion
HWM
HWM
STE
STE
Q4 25
1.76×
1.55×
Q3 25
1.38×
1.50×
Q2 25
1.10×
2.37×
Q1 25
0.74×
1.79×
Q4 24
1.53×
1.92×
Q3 24
0.73×
1.67×
Q2 24
1.49×
2.09×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HWM
HWM

Engine Products Segment$1.2B54%
Fastening Systems$454.0M21%
Forged Wheels$264.0M12%
Aerospace Defense$236.0M11%
Commercial Transportation$46.0M2%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons